°µÍø³Ô¹Ï
Main navigation
°µÍø³Ô¹Ï
°µÍø³Ô¹Ï
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy, Power & Infrastructure
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
News & Insights
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Log In
Log In
Read more
about MenloTherapeuticsInc-2018-01-25
$136.9 Million
Image
Menlo Therapeutics Inc.
Initial Public Offering
Active Bookrunner
Read more
about NeuroneticsInc-2018-06-28
$107.5 Million
Image
Neuronetics, Inc.
Initial Public Offering
Active Bookrunner
Read more
about DecipheraPharmaceuticalsInc-2017-09-27
$138.8 Million
Image
Deciphera Pharmaceuticals, Inc.
Initial Public Offering
Active Bookrunner
Read more
about ASLANPharmaceuticalsPteLtd-2018-05-04
$42.2 Million
Image
ASLAN Pharmaceuticals Pte. Ltd.
Initial Public Offering
Active Bookrunner
Read more
about DayOneBiopharmaceuticalsInc-2022-06-14
$172.5 Million
Image
Day One Biopharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
Read more
about CogentBiosciences-2022-06-13
$172.6 Million
Image
Cogent Biosciences
Follow-On Offering
Active Bookrunner
Read more
about LegendBiotech-2021-12-16
$344.6 Million
Image
Legend Biotech
Follow-On Offering
Active Bookrunner
Read more
about PriviaHealthGroupInc-2021-11-18
$174.0 Million
Image
Privia Health Group, Inc.
Follow-On Offering
Active Bookrunner
Read more
about FulcrumTherapeuticsInc-2021-08-11
$144.2 Million
Image
Fulcrum Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
Read more
about AligosTherapeutics-2021-06-30
$83.6 Million
Image
Aligos Therapeutics
Follow-On Offering
Active Bookrunner
Pagination
Previous page
‹â¶Ä¹
Page 22
Next page
›â¶Äº
Subscribe to Active Bookrunner